Luca Longo

3.3k total citations
55 papers, 1.4k citations indexed

About

Luca Longo is a scholar working on Neurology, Molecular Biology and Cancer Research. According to data from OpenAlex, Luca Longo has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Neurology, 21 papers in Molecular Biology and 20 papers in Cancer Research. Recurrent topics in Luca Longo's work include Neuroblastoma Research and Treatments (30 papers), Cancer, Hypoxia, and Metabolism (15 papers) and Lung Cancer Research Studies (9 papers). Luca Longo is often cited by papers focused on Neuroblastoma Research and Treatments (30 papers), Cancer, Hypoxia, and Metabolism (15 papers) and Lung Cancer Research Studies (9 papers). Luca Longo collaborates with scholars based in Italy, United Kingdom and United States. Luca Longo's co-authors include Gian Paolo Tonini, Simona Coco, Marilena De Mariano, Giovanni Rossi, Carlo Genova, Roberto Fusco, Patrizia Perri, Mario Capasso, F. Garbassi and Achille Iolascon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Luca Longo

52 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luca Longo Italy 24 639 581 446 393 267 55 1.4k
W. Clay Gustafson United States 19 1.6k 2.5× 530 0.9× 456 1.0× 487 1.2× 342 1.3× 38 2.3k
Daphne A. Haas-Kogan United States 23 1.4k 2.2× 232 0.4× 571 1.3× 534 1.4× 378 1.4× 34 2.5k
Spiros Linardopoulos United Kingdom 28 1.7k 2.7× 206 0.4× 337 0.8× 1.1k 2.9× 181 0.7× 71 2.5k
Patricia Armatis United States 31 759 1.2× 231 0.4× 302 0.7× 839 2.1× 222 0.8× 49 2.4k
Julie Staub United States 21 1.3k 2.0× 144 0.2× 438 1.0× 249 0.6× 84 0.3× 28 1.7k
Kenneth C. Petruk Canada 20 1.1k 1.7× 397 0.7× 630 1.4× 533 1.4× 485 1.8× 37 2.6k
Tracy Kerby United States 10 542 0.8× 186 0.3× 192 0.4× 227 0.6× 218 0.8× 13 1.1k
Evon Poon United Kingdom 14 789 1.2× 334 0.6× 338 0.8× 303 0.8× 87 0.3× 24 1.1k
Gian Paolo Tonini Italy 27 1.1k 1.8× 1.2k 2.1× 609 1.4× 394 1.0× 111 0.4× 85 1.9k
Steven J. Freedman United States 16 1.1k 1.8× 97 0.2× 656 1.5× 425 1.1× 111 0.4× 28 2.1k

Countries citing papers authored by Luca Longo

Since Specialization
Citations

This map shows the geographic impact of Luca Longo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Longo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Longo more than expected).

Fields of papers citing papers by Luca Longo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Longo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Longo. The network helps show where Luca Longo may publish in the future.

Co-authorship network of co-authors of Luca Longo

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Longo. A scholar is included among the top collaborators of Luca Longo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Longo. Luca Longo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Costa, Delfina, Roberta Venè, Simona Coco, et al.. (2023). SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation. Cells. 12(4). 664–664. 7 indexed citations
2.
Vezzulli, Luigi, Caterina Oliveri, Ismael A. Kimirei, et al.. (2021). Aquatic reservoir of Vibrio cholerae in an African Great Lake assessed by large scale plankton sampling and ultrasensitive molecular methods. ISME Communications. 1(1). 20–20. 7 indexed citations
3.
Rebuzzi, Sara Elena, Lodovica Zullo, Giovanni Rossi, et al.. (2021). Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 22(5). 2625–2625. 40 indexed citations
4.
Zullo, Lodovica, Giovanni Rossi, Chiara Dellepiane, et al.. (2021). Safety and Efficacy of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: Focus on Challenging Populations. Immunotherapy. 13(6). 509–525. 3 indexed citations
5.
Rossi, Giovanni, Lodovica Zullo, Luigi Cerbone, et al.. (2020). ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentarium. Expert Opinion on Pharmacotherapy. 21(6). 679–686. 2 indexed citations
6.
Rossi, Giovanni, Alessandro Russo, Marco Tagliamento, et al.. (2020). Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient. Cancers. 12(5). 1125–1125. 48 indexed citations
7.
Rossi, Giovanni, Alessandro Fedeli, Gianluca Ficarra, et al.. (2020). Radiomic Detection of EGFR Mutations in NSCLC. Cancer Research. 81(3). 724–731. 78 indexed citations
8.
Coco, Simona, Simona Boccardo, Marco Mora, et al.. (2020). Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer. Clinical Breast Cancer. 21(3). 218–230.e6. 2 indexed citations
9.
Rossi, Giovanni, Alessandro Russo, Marco Tagliamento, et al.. (2020). Präzisionsmedizin bei NSCLC im Zeitalter der Immuntherapie: Neue Biomarker zur Selektion der am besten geeigneten Therapie oder des am besten geeigneten Patienten. 8(6). 300–317. 1 indexed citations
10.
Brizzolara, Antonella, Serena Vella, Alessandro Quattrone, et al.. (2020). Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma Treatment. Molecules. 25(22). 5234–5234. 6 indexed citations
11.
Genova, Carlo, Simona Coco, Giovanni Rossi, et al.. (2020). 1277P An exosomal miRNA signature as predictor of benefit from immune checkpoint inhibitors in non-small cell lung cancer. Annals of Oncology. 31. S825–S826. 2 indexed citations
12.
Alama, Angela, Simona Coco, Carlo Genova, et al.. (2019). Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab. Journal of Clinical Medicine. 8(7). 1011–1011. 45 indexed citations
13.
Rijavec, Erika, Simona Coco, Carlo Genova, et al.. (2019). Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges. Cancers. 12(1). 17–17. 93 indexed citations
14.
Sidarovich, Viktoryia, Marilena De Mariano, Sanja Aveic, et al.. (2018). A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy. Molecular Cancer Therapeutics. 17(7). 1405–1415. 29 indexed citations
15.
Aveic, Sanja, Viktoryia Sidarovich, Marilena De Mariano, et al.. (2018). Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors. Cancer Cell International. 18(1). 63–63. 20 indexed citations
16.
Longo, Luca, Simona Vatrano, Susanna Cappia, et al.. (2014). Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis.. PubMed. 37(2). 129–43. 25 indexed citations
17.
Coco, Simona, Marilena De Mariano, Francesca Valdora, et al.. (2012). Identification of ALK germline mutation (3605delG) in pediatric anaplastic medulloblastoma. Journal of Human Genetics. 57(10). 682–684. 15 indexed citations
18.
Grosso, Federica, Simona Coco, Paola Scaruffi, et al.. (2011). Role of CXCL13-CXCR5 Crosstalk Between Malignant Neuroblastoma Cells and Schwannian Stromal Cells in Neuroblastic Tumors. Molecular Cancer Research. 9(7). 815–823. 26 indexed citations
19.
Passoni, Lorena, Luca Longo, Paola Collini, et al.. (2009). Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients. Cancer Research. 69(18). 7338–7346. 129 indexed citations
20.
Perri, Patrizia, Tiziana Bachetti, Luca Longo, et al.. (2005). PHOX2B mutations and genetic predisposition to neuroblastoma. Oncogene. 24(18). 3050–3053. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Clay Gustafson Breakdown of academic impact, for papers by Daphne A. Haas-Kogan Breakdown of academic impact, for papers by Spiros Linardopoulos Breakdown of academic impact, for papers by Patricia Armatis Breakdown of academic impact, for papers by Julie Staub Breakdown of academic impact, for papers by Kenneth C. Petruk Breakdown of academic impact, for papers by Tracy Kerby Breakdown of academic impact, for papers by Evon Poon Breakdown of academic impact, for papers by Gian Paolo Tonini Breakdown of academic impact, for papers by Steven J. Freedman
Rankless by CCL
2026